To access any content or REGISTER in less than 3 minutes.
Register
Menu
Are you medical worker?
No, visit
Your account was deleted
Please login to MyServier to continue reading this content

Don't have an account? REGISTER

You already have an account associated with this email address. Please log in to continue.

Don't have an account? REGISTER

Forgot Password?
Please enter the email address here. We will then immediately send you a link with which you can create a new password.
Your email
Link sent successfully
Check the email sent to you for further instructions. Check your junk folder if you can't find it.

Video

  • Cardiology
  • Cardiometabolic Risk
  • Heart Failure
  • Ischemic Heart Disease

How does the early combination of a metabolic modulator with an hemodynamic agent weighs clinically ?

You are registered for this event You have rejected invitation for this event
17.04.2026
5

Medical Dialogues – Daily Dose of Health & Medical News

In this video, Dr. Abhishek Shukla presents the COMBINE Angina study, highlighting how the early addition of trimetazidine (a metabolic modulator) to hemodynamic therapy significantly reduces angina episodes and improves physical capacity and quality of life for patients.

Dr. Abhishek Shukla – Consultant Cardiologist – Ajanta Hospital, Lucknow, India

Watch the full video to learn more!

Content exclusive for connected users. Please sign in or register to access more.

Already have an account?

New here?

Create account

Related content: